Bloomberg Dollar Index rises 0.3%, recovering half of its losses since the "Basente repurchase."

As of the 23:00 close, most of the domestic futures main contracts rose. Rapeseed meal and liquefied petroleum gas (LPG) increased by nearly 2%; No.2 soybean, soybean meal, and asphalt rose by more than 1%; fuel oil and soybean oil were up nearly 1%. On the downside, soda ash and ethylene glycol (EG) dropped by over 2%; PET bottle-grade chips, short fiber, methanol, and paraxylene fell by more than 1%; caustic soda and coke declined by nearly 1%.

Spot gold falls below $4,590 per ounce, down 1.50% on the day.

China's INE crude oil futures main contract has just broken through the 570.0 yuan/barrel mark, now quoted at 570.4 yuan/barrel, up 1.05% for the day.

Revolution Medicines’ pancreatic cancer drug Daraxonrasib has been approved by U.S. regulators, making it the first drug targeting one of the key molecular pathogenic mechanisms of pancreatic cancer. The drug will be marketed under the name Rasonque and is considered one of the most important breakthroughs in pancreatic cancer treatment in recent years. According to data from the U.S. Food and Drug Administration (FDA), a late-stage clinical trial published in May showed that for a particularly